Current management of patients with hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Current management of patients with hepatocellular carcinoma.

Current management of patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35895363

about

Hepatocellular carcinoma: Where are we?Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.Preventive Effect of Geraniol on Diethylnitrosamine-Induced Hepatocarcinogenesis in Rats.Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma.Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling.Preventive Effects of Vitamin C on Diethylnitrosamine-induced Hepatotoxicity in Smp30 Knockout Mice.miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression.Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma.

P2860

Q26765182-09D677DA-7D1B-4317-969F-B06F80FD1B4F Q33591514-F77B522A-1EAA-444C-9F9A-7C82CFA3077A Q36753890-C89C074B-D2B6-4C49-AE93-833438E85C32 Q37636703-490682BD-9177-4E9A-AD44-1199FA31FA97 Q38802507-D9A71373-8295-4106-997E-0E729BF9EE41 Q42523379-CA4D76F7-4BF3-4BB7-B50D-21345C406D34 Q47171889-02A7D47B-43D3-4E8C-AE4E-3F8A0134AE1F Q47257473-EC8A5048-7F8C-4285-9833-6A100F625421 Q49729843-ECC5582D-C153-4BC3-915B-97537DF62429 Q50239119-9BB8A925-9586-4713-991F-0F6FB4538056

P2860

Current management of patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35895363

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Current management of patients with hepatocellular carcinoma.

@ast

Current management of patients with hepatocellular carcinoma.

@en

type

label

Current management of patients with hepatocellular carcinoma.

@ast

Current management of patients with hepatocellular carcinoma.

@en

prefLabel

Current management of patients with hepatocellular carcinoma.

@ast

Current management of patients with hepatocellular carcinoma.

@en

P1433

Q35895363-1C7155EC-2FF1-41A7-A873-F29AE9F96C18

P1476

Q35895363-EE47777A-EDD0-422E-99A5-CEE02CFC945E

P2093

Q35895363-16EC2394-6214-4411-90E9-6EB7AF34FAFA

Q35895363-342451CD-ED30-468B-B077-B4E9E15231AE

Q35895363-4FF66174-8A7F-4987-9A9F-EF6E5513F670

Q35895363-77B27561-BF8C-45F4-B73D-C16ACD40058D

Q35895363-AD745A90-DE16-49EF-B384-DD1FEDADDDD8

Q35895363-FF462072-AABD-4139-BFDC-334BC764A144

P2860

Q35895363-0515A9C4-6679-4CD4-B489-C41489E293E2

Q35895363-075DD2BA-5A75-4D6D-AE84-391F965B35F0

Q35895363-12025A6D-F485-4C11-8229-93E1CB55AB04

Q35895363-1CC15036-E629-4CAB-B9B9-3D1984DF6B94

Q35895363-20E7F1B4-863B-4A70-A531-301DF2743D5A

Q35895363-283230A5-BBA8-41E4-9E0A-A2205EF4E205

Q35895363-29695EDA-B9F9-4B79-8121-161EF6F0238B

Q35895363-2A032BE5-FBE9-4B81-B8DF-2C218060B98D

Q35895363-2B813530-FB81-4430-A652-337271A36085

Q35895363-2B8171B8-1DDE-48FD-8B03-BF3A503FAE2D

P304

Q35895363-913E0381-F990-4207-8B6F-A273D3D98AA9

P31

Q35895363-5C93CE0F-F230-46C3-928A-B1B5BDD6A66E

Q35895363-6fff00a2-17f4-4fdf-ba39-aa4f551ae2b5

P356

Q35895363-EB744AD2-D337-4BD8-A98D-EF86BDE77997

P433

Q35895363-249A0B84-6C65-4642-8481-929660E01A93

P478

Q35895363-FD1EA9AD-9F8F-45C1-8D12-F21430863C2E

P577

Q35895363-C6D62424-4A95-49DD-82C8-CC623D4D4E17

P5875

Q35895363-4CC84235-B277-48EB-8FB7-27DECB295072

P698

Q35895363-5F48DC72-41E8-4197-83BE-5032E9B3C25F

P932

Q35895363-39A20664-FB74-424A-AFE6-18402C8ED7FA

P356

WJH.V7.I15.1913

P1433

World journal of hepatology

P1476

Current management of patients with hepatocellular carcinoma.

@en

P2093

Masao Omata

http://www.w3.org/2001/XMLSchema#string

Osamu Yokosuka

http://www.w3.org/2001/XMLSchema#string

Sadahisa Ogasawara

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kanda

http://www.w3.org/2001/XMLSchema#string

Tetsuhiro Chiba

http://www.w3.org/2001/XMLSchema#string

Yuki Haga

http://www.w3.org/2001/XMLSchema#string

P2860

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors

Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Epidemiology of viral hepatitis and hepatocellular carcinoma

P304

1913-1920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V7.I15.1913

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280871926

http://www.w3.org/2001/XMLSchema#string

P698

26244066

http://www.w3.org/2001/XMLSchema#string

P932

4517151

http://www.w3.org/2001/XMLSchema#string